Skip to content

Contact +44 (0) 20 7060 7474 email us

Pipeline

Cook Medical Product Pipeline Analysis

 

Publication Date August 2008
Publisher Global Markets Direct
Product Type Report
Pages 89
ISBN Number not applicable
Product Code GMD00595

Price

£500.00
approximately: $751 | €548

pdf

Buy Now

Order above formats by FAX

Order by Fax

Summary

This report is an insightful source for data, analysis and strategic insights into a Cook Medical's pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

  • Details of development stage by sector and equipment type.
  • Pipeline products grouped by therapy area, development stage and trial phase.
  • Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
  • Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
  • Product updates covering estimated approval dates and estimated launch dates.
  • Descriptions of novel technologies relating to pipeline products of the company.
  • Patents and patent applications covered for the product.
  • News updates on key events relating to the product and its development.

Reasons to buy

  • A single source to fulfill competitor information relating to products in development.
  • Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

  • Access clinical trial information to map trial results and plan targeted marketing activities.
  • Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
  • Identification of potential investment opportunities.
  • Build up knowledge base for potential distribution and marketing partners.
  • Helps avoid patent infringement.
  • Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Contents

  • 1 List of Tables
    • 1.2 List of Figures
  • 2 Company Snapshot
    • 2.1 Key Information
    • 2.2 Company Overview
    • 2.3 Industry Outlook - Cardiovascular Devices
    • 2.4 Industry Outlook - Endoscopy Devices
  • 3 Business Description
    • 3.1 Business Overview
    • 3.2 Major Products and Services
      • 3.2.1 Overview
  • 4 History
  • 5 Competitors
  • 6 Key Employees
  • 7 Key Employee Biographies
  • 8 Locations And Subsidiaries
    • 8.1 Head Office
    • 8.2 Other Locations & Subsidiaries
  • 9 Recent Developments
    • 9.1 Strategy And Business Planning
      • 9.1.1 Feb 06, 2008: Cook Pharmica Announces $80 Million Capability Expansion
      • 9.1.2 Sep 20, 2007: Cook Medical, Cardica Sign Agreement
      • 9.1.3 Jun 19, 2007: Cardica And Cook Medical Announces Collaboration Agreement
    • 9.2 Corporate Communications
      • 9.2.1 Feb 20, 2008: Cook Medical Appoints CSO
      • 9.2.2 Feb 08, 2008: Cook Medical Promotes Director
      • 9.2.3 Feb 05, 2008: Cook Medical Appoints New Vice President
      • 9.2.4 Feb 05, 2008: Cook Medical Appoints Vice President
      • 9.2.5 Jun 15, 2007: Cook Medical Names Vice Presidents
      • 9.2.6 May 30, 2007: Cook Medical Promotes VP
      • 9.2.7 Jan 23, 2007: Cook Medical Appoints SVP Regulatory Affairs
      • 9.2.8 Jan 23, 2007: Cook Appoints VP, Diagnostic And Interventional Products Division
      • 9.2.9 Jan 23, 2007: Cook Medical Appoints New Directors
    • 9.3 Legal and Regulatory
      • 9.3.1 Mar 31, 2008: Cook Medical Wins Injunction Against Endologix And Former Sales Representatives Over Violations of Employee Non-Compete Agreements
      • 9.3.2 Mar 21, 2008: Cook Wins Patent Infringement Suit With Edwards
    • 9.4 Product News
      • 9.4.1 Aug 05, 2008: Cook Medical And Boston Scientific: GI Stent Market Evolution: Colonic stents
      • 9.4.2 Aug 05, 2008: Cook Medical And Boston Scientific: GI Stent Market Evolution: Duodenal stents
      • 9.4.3 Aug 04, 2008: Cook Medical Receives FDA Approval To Market Z-Trak Introduction System
      • 9.4.4 Aug 04, 2008: Cook Medical Receives FDA Approval To Market Zenith AAA Iliac Flex Legs
      • 9.4.5 Jul 19, 2008: Launch Of Zenith AAA Iliac Legs With Flex Stent Gapping Designed To Have Increased Flexibility And Improved Conformability
      • 9.4.6 Jul 08, 2008: Complex Aneurysm Treated Using New Fenestrated Endograft Stent
      • 9.4.7 Jul 07, 2008: Foothills Medical Centre Adopts Newest Technology For The Removal Of Pacemaker Leads
      • 9.4.8 Jun 25, 2008: US Multicenter Trial Shows Positive Results Using Cook Medical's Zenith Abdominal Aortic Aneurysm Endovascular Stent Compared To Open Surgical Repair
      • 9.4.9 Jun 24, 2008: Cook Medical Announces The First Commercial Placement Of The Zenith TX2 TAA Endovascular Graft In The United States
      • 9.4.10 Jun 16, 2008: Cook Medical Enters Coronary Stent Market In Europe With New CoCr Stent
      • 9.4.11 Jun 11, 2008: Interim Results For The Zilver PTX Clinical Study From Cook Medical Show Promise For Improving The Treatment Of Blockages In The Femoropopliteal Artery
      • 9.4.12 Jun 03, 2008: Cook Medical Announces First-In-Man Use Of Next Generation Aortic Aneurysm Endograft And Delivery System
      • 9.4.13 May 23, 2008: Cook Medical Announces FDA 510(k) Clearance Of Evolution Controlled Release Esophageal Stent System
      • 9.4.14 May 23, 2008: Cook Medical Receives FDA Approval For Advanced Thoracic Aortic Aneurysm Endovascular Graft
      • 9.4.15 May 16, 2008: Foothills Medical Centre Adopts Newest Technology For The Removal Of Pacemaker Leads
      • 9.4.16 May 14, 2008: Cook Medical Launches EVOLUTION-Shortie Mechanical Dilator Sheath Set For Vessel Access Associated With Lead Extraction
      • 9.4.17 Apr 28, 2008: Minocycline/Rifampin Catheters Shown To Reduce Microbial Resistance
      • 9.4.18 Apr 04, 2008: Angiotech Announces Commercial Launch Of Cook Medical's Zilver PTX Drug-Eluting Peripheral Stent In New Zealand
      • 9.4.19 Mar 31, 2008: Cook Medical Advances Staple Line Reinforcement With Self-Adhesive Surgisis Biodesign
      • 9.4.20 Mar 22, 2008: Cook Medical Announces First Enrolment In European Arm Of Global Trial Of Unique Device To Treat Aortic Dissection
      • 9.4.21 Mar 19, 2008: Cook Medical Announces The Launch And First Patient Enrollment Of The REFORM Clinical Trial
      • 9.4.22 Mar 19, 2008: Cook Medical Receives 510(k) Clearance For Gunther Tulip Vena Cava Filter Retrieval Set
      • 9.4.23 Mar 19, 2008: Cook Medical Receives FDA 510(k) Clearance For Celect Vena Cava Filter
      • 9.4.24 Mar 19, 2008: Cook Medical Receives FDA 510(k) Clearance For Celect Vena Cava Filter
      • 9.4.25 Feb 22, 2008: Cook Medical Launches Spectrum Glide To Combat Catheter Related Bloodstream Infections
      • 9.4.26 Feb 13, 2008: Cook Medical Introduces Umbilical Hernia Graft Designed To Fit Individual Patient Anatomies
      • 9.4.27 Feb 11, 2008: Cook Medical Enrolls First US Patient In STABLE Aortic Dissection Trial
      • 9.4.28 Feb 01, 2008: Cook Medical Applauds StudyReporting High Success Rates Of Endovascular Aortic Repair
      • 9.4.29 Nov 30, 2007: Cook Medical Launches EVOLUTION For Lead Extraction
      • 9.4.30 Nov 14, 2007: Cook Medical Introduces The 36mm Diameter Zenith Renu AAA Ancillary Graft At The 34th Annual VEITHsymposium
      • 9.4.31 Oct 08, 2007: Research Indicates 86 Percent Success Rate For Anal Fistula Repair Utilizing Surgisis Biodesign
      • 9.4.32 Sep 27, 2007: Cook Medical Receives FDA Approval To Begin US Phase I Clinical Trial For Cook Zenith Dissection Endovascular System
      • 9.4.33 Aug 23, 2007: Surgisis Biodesign For Pelvic Floor Repair Now Anatomically Shaped For More Accurate And Consistent Placement During Surgery
      • 9.4.34 Jul 16, 2007: US Patients Treated With New Drug-Coated Stent-First International Study Of Paclitaxel-Coated Stent For Use Outside The Heart
      • 9.4.35 Jul 11, 2007: First Patients Treated With New Drug-Coated Stent - Trial Is First International Study Of Paclitaxel-Coated Stent For Use Outside The Heart
      • 9.4.36 Jul 10, 2007: International Clinical Trial Shows Positive Results Using Cook Medical's Zenith TX2 Thoracic Aortic Aneurysm Endovascular Graft
      • 9.4.37 Apr 30, 2007: Lunderquist Extra Stiff Wire Guides
      • 9.4.38 Apr 24, 2007: Replay Of Thoracic Aortic Aneurysm Repair Featuring Cook Zenith TX2 Endovascular Graft And New Z-Trak Plus Introduction System
      • 9.4.39 Mar 29, 2007: Breakthrough Clinical Results Reveal Extended Retrieval Times For Cook Medical''s Gunther Tulip Vena Cava Filter
      • 9.4.40 Mar 01, 2007: Cook Medical''s Zilver Stent Approved For Vascular Use In Canada
      • 9.4.41 Jan 30, 2007: First International Trial Of Paclitaxel-Eluting Peripheral Artery Stent Results Encouraging
      • 9.4.42 Jan 22, 2007: Cook Reports Preliminary Reimbursement For Endovascular AAA Repair In Japan
      • 9.4.43 Jul 31, 2006: Cook Incorporated Completes Enrollment Of Patients In STARZ-TX2 Trial
      • 9.4.44 Jul 25, 2006: FDA Clears Latest Version of Central Venous Catheter from Cook Incorporated
      • 9.4.45 Apr 26, 2006: Cook Inc.''s Zenith Fenestrated Endograft Successfully Implanted In 1,000th Case To Treat Complex Abdominal Aortic Aneurysms
      • 9.4.46 Oct 25, 2005: Cook Offers First Fenestrated Endograft With CE Mark Approval For Complex Aortic Aneurysms
      • 9.4.47 Aug 08, 2005: Cook Offers First Fenestrated Endograft With CE Mark Approval For Complex Aortic Aneurysms
      • 9.4.48 Jan 25, 2005: Cook Incorporated Continues to Revolutionize Endovascular Aortic Repair Procedure
      • 9.4.49 Jan 19, 2005: Cook Incorporated Announces Implant Of Zenith TX2 Endovascular Graft At ISET 2005
      • 9.4.50 Jan 07, 2005: First Fenestrated Endograft In Cook Inc.'s Study Of Advanced Treatment For Aortic Aneurysms Is Implanted In U.S
      • 9.4.51 Aug 31, 2004: FDA Clears New Hydrophilic Antimicrobial Catheter From Cook Critical Care For U.S. Sales
      • 9.4.52 Aug 31, 2004: FDA Clears New Hydrophilic Antimicrobial Catheter From Cook Critical Care For US Sales
      • 9.4.53 Aug 31, 2004: FDA Clears New Hydrophilic Antimicrobial Catheter From Cook Critical Care For US Sales
      • 9.4.54 Aug 31, 2004: FDA Clears New Hydrophilic Antimicrobial Catheter From Cook Critical Care For US Sales
      • 9.4.55 Jul 14, 2004: Cook Incorporated To Begin First US Clinical Investigation Of A Fenestrated AAA Endovascular Graft
      • 9.4.56 Apr 12, 2004: Cook Incorporated Begins US Clinical Trial Of Zenith TX2 THORACIC Aortic Aneurysm Endograft
      • 9.4.57 Dec 09, 2003: Cook Incorporated Receives FDA Approval For Clinical Investigation Of Zenith TX2 Thoracic Aneurysm Graft
    • 9.5 Product Approvals
      • 9.5.1 Aug 04, 2008: Cook Medical Receives FDA Approval To Market Zenith AAA Iliac Flex Legs
      • 9.5.2 Aug 04, 2008: Cook Medical Receives FDA Approval To Market Z-Trak Introduction System
      • 9.5.3 Jun 16, 2008: Cook Medical Enters Coronary Stent Market In Europe With New CoCr Stent
      • 9.5.4 May 23, 2008: Cook Medical Announces FDA 510(k) Clearance Of Evolution Controlled Release Esophageal Stent System
      • 9.5.5 May 23, 2008: Cook Medical Receives FDA Approval For Advanced Thoracic Aortic Aneurysm Endovascular Graft
      • 9.5.6 Mar 19, 2008: Cook Medical Receives FDA 510(k) Clearance For Celect Vena Cava Filter
      • 9.5.7 Mar 19, 2008: Cook Medical Receives 510(k) Clearance For Gunther Tulip Vena Cava Filter Retrieval Set
      • 9.5.8 Mar 19, 2008: Cook Medical Receives FDA 510(k) Clearance For Celect Vena Cava Filter
      • 9.5.9 Mar 01, 2007: Cook Medical''s Zilver Stent Approved For Vascular Use In Canada
      • 9.5.10 Jul 25, 2006: FDA Clears Latest Version of Central Venous Catheter from Cook Incorporated
      • 9.5.11 Oct 25, 2005: Cook Offers First Fenestrated Endograft With CE Mark Approval For Complex Aortic Aneurysms
      • 9.5.12 Aug 08, 2005: Cook Offers First Fenestrated Endograft With CE Mark Approval For Complex Aortic Aneurysms
      • 9.5.13 Aug 31, 2004: FDA Clears New Hydrophilic Antimicrobial Catheter From Cook Critical Care For U.S. Sales
      • 9.5.14 Aug 31, 2004: FDA Clears New Hydrophilic Antimicrobial Catheter From Cook Critical Care For US Sales
      • 9.5.15 Aug 31, 2004: FDA Clears New Hydrophilic Antimicrobial Catheter From Cook Critical Care For US Sales
      • 9.5.16 Aug 31, 2004: FDA Clears New Hydrophilic Antimicrobial Catheter From Cook Critical Care For US Sales
      • 9.5.17 Jul 14, 2004: Cook Incorporated To Begin First US Clinical Investigation Of A Fenestrated AAA Endovascular Graft
      • 9.5.18 Dec 09, 2003: Cook Incorporated Receives FDA Approval For Clinical Investigation Of Zenith TX2 Thoracic Aneurysm Graft
    • 9.6 Clinical Trials
      • 9.6.1 Jul 08, 2008: Complex Aneurysm Treated Using New Fenestrated Endograft Stent
      • 9.6.2 Jun 25, 2008: US Multicenter Trial Shows Positive Results Using Cook Medical's Zenith Abdominal Aortic Aneurysm Endovascular Stent Compared To Open Surgical Repair
      • 9.6.3 Jun 11, 2008: Interim Results For The Zilver PTX Clinical Study From Cook Medical Show Promise For Improving The Treatment Of Blockages In The Femoropopliteal Artery
      • 9.6.4 Jun 03, 2008: Cook Medical Announces First-In-Man Use Of Next Generation Aortic Aneurysm Endograft And Delivery System
      • 9.6.5 Apr 28, 2008: Minocycline/Rifampin Catheters Shown To Reduce Microbial Resistance
      • 9.6.6 Mar 22, 2008: Cook Medical Announces First Enrolment In European Arm Of Global Trial Of Unique Device To Treat Aortic Dissection
      • 9.6.7 Mar 19, 2008: Cook Medical Announces The Launch And First Patient Enrollment Of The REFORM Clinical Trial
      • 9.6.8 Feb 11, 2008: Cook Medical Enrolls First US Patient In STABLE Aortic Dissection Trial
      • 9.6.9 Feb 01, 2008: Cook Medical Applauds StudyReporting High Success Rates Of Endovascular Aortic Repair
      • 9.6.10 Oct 08, 2007: Research Indicates 86 Percent Success Rate For Anal Fistula Repair Utilizing Surgisis Biodesign
      • 9.6.11 Sep 27, 2007: Cook Medical Receives FDA Approval To Begin US Phase I Clinical Trial For Cook Zenith Dissection Endovascular System
      • 9.6.12 Jul 16, 2007: US Patients Treated With New Drug-Coated Stent-First International Study Of Paclitaxel-Coated Stent For Use Outside The Heart
      • 9.6.13 Jul 11, 2007: First Patients Treated With New Drug-Coated Stent - Trial Is First International Study Of Paclitaxel-Coated Stent For Use Outside The Heart
      • 9.6.14 Jul 10, 2007: International Clinical Trial Shows Positive Results Using Cook Medical's Zenith TX2 Thoracic Aortic Aneurysm Endovascular Graft
      • 9.6.15 Mar 29, 2007: Breakthrough Clinical Results Reveal Extended Retrieval Times For Cook Medical''s Gunther Tulip Vena Cava Filter
      • 9.6.16 Jan 30, 2007: First International Trial Of Paclitaxel-Eluting Peripheral Artery Stent Results Encouraging
      • 9.6.17 Jul 31, 2006: Cook Incorporated Completes Enrollment Of Patients In STARZ-TX2 Trial
      • 9.6.18 Apr 26, 2006: Cook Inc.''s Zenith Fenestrated Endograft Successfully Implanted In 1,000th Case To Treat Complex Abdominal Aortic Aneurysms
      • 9.6.19 Jan 07, 2005: First Fenestrated Endograft In Cook Inc.'s Study Of Advanced Treatment For Aortic Aneurysms Is Implanted In U.S
      • 9.6.20 Apr 12, 2004: Cook Incorporated Begins US Clinical Trial Of Zenith TX2 THORACIC Aortic Aneurysm Endograft
    • 9.7 Other Significant Developments
      • 9.7.1 Jun 18, 2008: Cook Medical Wins Contract With HealthTrust To Supply Medical Devices
  • 10 Cook Medical Pipeline Products
    • 10.1 Cook Medical Product Pipeline Analysis
      • 10.1.1 Cook Medical Pipeline Products By Equipment Type
      • 10.1.2 Cook Medical Pipeline Products By Development Stage
      • 10.1.3 Cook Medical Pipeline Products By Therapy Area
      • 10.1.4 Cook Medical Pipeline Products By Clinical Trials
      • 10.1.5 Cook Medical Pipeline Products By News Summary
    • 10.2 ZILVER PTX Paclitaxel-Eluting Peripheral Vascular Stent
      • 10.2.1 Product Description
      • 10.2.2 Product Status
      • 10.2.3 Clinical Trials
      • 10.2.4 Product Milestone
      • 10.2.5 Product Patent Details
    • 10.3 Cook Magnetic Anastomosis Device
      • 10.3.1 Product Description
      • 10.3.2 Product Status
      • 10.3.3 Clinical Trials
      • 10.3.4 Product Patent Details
    • 10.4 Zenith Dissection Endovascular System
      • 10.4.1 Product Description
      • 10.4.2 Product Status
      • 10.4.3 Clinical Trials
      • 10.4.4 Product Milestone
    • 10.5 Cook's Zenith 36mm Diameter Renu AAA Ancillary Graft
      • 10.5.1 Product Description
      • 10.5.2 Product Status
      • 10.5.3 Product Milestone
    • 10.6 Formula Balloon Expandable Stent
      • 10.6.1 Product Description
      • 10.6.2 Product Status
      • 10.6.3 Clinical Trials
      • 10.6.4 Product Milestone
  • 11 Appendix
    • 11.1 Methodology
      • 11.1.1 Coverage
      • 11.1.2 Secondary Research
      • 11.1.3 Primary Research
      • 11.1.4 Expert Panel Validation
    • 11.2 Contact Us
    • 11.3 About Global Markets Direct
    • 11.4 Disclaimer
  • 1 List of Tables
    • Table 1: Cook Medical,Key Facts
    • Table 2: Cook Medical, Key Employees,
    • Table 3: Cook Medical, Other Locations
    • Table 4: Cook Medical, Subsidiaries
    • Table 5: Cook Medical Pipeline Products by Equipment Type
    • Table 6: Cook Medical Pipeline Products By Development Stage
    • Table 7: Cook Medical Pipeline Products By Therapy Area
    • Table 8: Cook Medical Pipeline Products By Clinical Trials
    • Table 9: Cook Medical Pipeline Products By News Summaries
    • 1.2 List of Figures
    • Figure 1: Cook Medical Pipeline Products By Equipment Type
    • Figure 2: Cook Medical Pipeline Products By Equipment Type
    • Figure 3: Cook Medical Pipeline Products By Development Stage
    • Figure 4: Cook Medical Pipeline Products By News Summary
    • Figure 5: Global Markets Direct Methodology
Product Features / Use
Scope Expert Insight/Opinion
Level Management Strategy
Profiles In-depth Company Insight
Features Primary Research Data